KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $0.87 $1.65 Friday, 26th Apr 2024 ADAP stock ended at $1.08. This is 1.42% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 5.83% from a day low at $1.03 to a day high of $1.09.
90 days $0.730 $2.05
52 weeks $0.420 $2.05

Historical Adaptimmune Therapeutics plc prices

Date Open High Low Close Volume
Jul 14, 2021 $3.88 $3.90 $3.70 $3.73 550 588
Jul 13, 2021 $3.94 $3.95 $3.81 $3.87 422 740
Jul 12, 2021 $4.13 $4.17 $3.93 $3.95 211 973
Jul 09, 2021 $4.07 $4.11 $3.99 $4.10 193 540
Jul 08, 2021 $3.89 $4.05 $3.87 $4.03 375 009
Jul 07, 2021 $4.17 $4.17 $3.90 $4.01 566 111
Jul 06, 2021 $4.27 $4.28 $4.11 $4.15 432 518
Jul 02, 2021 $4.37 $4.37 $4.22 $4.31 275 176
Jul 01, 2021 $4.27 $4.39 $4.22 $4.35 448 660
Jun 30, 2021 $4.40 $4.40 $4.22 $4.26 528 089
Jun 29, 2021 $4.38 $4.45 $4.30 $4.39 447 589
Jun 28, 2021 $4.35 $4.45 $4.31 $4.41 553 216
Jun 25, 2021 $4.32 $4.42 $4.26 $4.35 440 100
Jun 24, 2021 $4.15 $4.34 $4.15 $4.28 859 262
Jun 23, 2021 $3.90 $4.24 $3.87 $4.16 1 141 139
Jun 22, 2021 $3.91 $3.95 $3.67 $3.86 1 794 830
Jun 21, 2021 $3.99 $4.10 $3.88 $3.90 1 082 381
Jun 18, 2021 $4.16 $4.19 $3.89 $3.95 2 241 347
Jun 17, 2021 $4.00 $4.22 $3.93 $4.18 1 385 239
Jun 16, 2021 $4.07 $4.16 $4.02 $4.03 1 265 565
Jun 15, 2021 $4.48 $4.53 $3.80 $4.14 2 663 444
Jun 14, 2021 $4.46 $4.52 $4.42 $4.49 679 010
Jun 11, 2021 $4.65 $4.70 $4.44 $4.46 844 110
Jun 10, 2021 $4.60 $4.71 $4.45 $4.65 640 129
Jun 09, 2021 $4.71 $4.75 $4.57 $4.62 624 967
Click to get the best stock tips daily for free!

About Adaptimmune Therapeutics plc

Adaptimmune Therapeutics plc Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States and the United Kingdom. The company's specific peptide enhanced affinity receptor (SPEAR) T-cell platform enables it to identify cancer targets. It is developing ADP-A2M4 that is in phase II clinical trials with SPEARHEAD-1 for synovial sarcoma and myxoid round cell liposa... ADAP Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT